Shefali Agarwal was named chief medical officer of Epizyme Inc. In this role, Agarwal will oversee all of the company's activities related to the global strategic development of tazemetostat, a potent, selective, orally available EZH2 inhibitor, as well as additional pipeline candidates.
Indiana University Distinguished Professor Hal Broxmeyer received the National Heart, Lung, and Blood Institute Outstanding Investigator Award to continue his 35 years of research into umbilical cord blood transplantation.
Trevor Royce and Sheetal Kircher have been selected for the American Society of Clinical Oncology Health Policy Fellowship Program.
A $26.5 million study will investigate environmental and genetic factors related to aggressiveness of prostate cancer in African-American men to better understand why they disproportionally experience aggressive disease—cancer that grows and spreads quickly—compared with men of other racial and ethnic groups.
The National Coalition for Cancer Survivorship was awarded a grant from the American Institutes for Research, with support from the Robert Wood Johnson Foundation, to develop a new quality measure concept for “return to functional status.”
CureSearch has named the 2018 Young Investigator Award recipients: Loretta Li of the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Avery Posey of Children's Hospital of Philadelphia.
The American Academy of Nursing has inducted its class of 2018 Academy fellows on June 28, 2018. Sixteen ONS members were included among the nurse leaders who join the ranks of Academy fellows to be celebrated at AAN's annual policy conference.
Pediatric surgeon J. Ted Gerstle was named chief of the Pediatric Surgery Service in the Department of Surgery at Memorial Sloan Kettering Cancer Center.
Richard Pestell will join CytoDyn Inc. of Vancouver as chief medical officer.
Rob Beck was named Chief Operating Officer of the Leukemia & Lymphoma Society.
